ClinicalTrials.gg
Not yet recruitingNCT07801261Updated Sep 3, 2026

Evaluation of Functional Disability in Rheumatoid Arthritis Patients

An observational study in Rheumatoid Arthritis (RA), sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Sohag University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Arthritis, Rheumatoid by Sohag University — 10 open to participants now, 11 under way, 1 of them phase 3. Arthritis, Rheumatoid · Sohag University.

Planned enrollment
3rd of 12
150 · median 126
Started
2026
with 5 others
Observational
12 of 20
7 open now
Primary completion
2027-01
later than 5 of 10 live
Registered
18th of 20
by date

Among the 20 studies in Arthritis, Rheumatoid by Sohag University, this one is the 3rd largest by planned enrollment of the 12 observational ones that give a count, is one of 6 that started in 2026, is one of 12 observational ones, reaches primary completion later than 5 of the 10 other live ones, and was the 18th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

10 of the 20 studies in Arthritis, Rheumatoid by Sohag University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Arthritis, Rheumatoid by Sohag University, or all of them as a file.
02

Study summary

Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune inflammatory disease that mainly affects the joints and periarticular soft tissues. Accurate monitoring of disease activity is a cornerstone of the treat-to-target approach in Rheumatoid arthritis.

03

Conditions studied

  • Rheumatoid Arthritis (RA)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This study will include 100 established Rheumatoid arthritis (RA) patients according the 2010 ACR/EULAR classification criteria for RA, who will be recruited from Rheumatology and Rehabilitation department at Sohag university hospital, in addition to 50 controls will be matched for sex, age, and level of schooling

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Patients fulfill the 2010 ACR/EULAR classification criteria of Rheumatoid arthritis is based on the confirmed presence of synovitis in at least one joint, absence of an alternative diagnosis better explaining the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in four domains :

      1. number and site of involved joints (range 0-5)
      2. serological abnormality (range 0-3)
      3. elevated acute-phase response (range 0-1)
      4. symptom duration (two levels; range 0-1).

        • Age above 18 years old.
        • Patient cooperative and can answer questions

Exclusion criteria

Exclusion Criteria:

    • Other rheumatologic or collagen diseases.

      • Age below 18 years and above 65 years.
      • Uncooperative patients.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • rheumatoid arthritis established patients
  • control group of non rheumatoid patients
06

What researchers measure

Primary outcomes

  1. To evaluate the performance of Rheumatoid Arthritis Impact of Disease (RAID) questionnaire in detecting disease flares in Rheumatoid arthritis patients and to compare it with other disease activity indices.

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jan 2027, 5 months later.

Of 235 non-industry observational studies under Arthritis, Rheumatoid, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 122. This study's planned 5 months is below that.

Counting every sponsor, half of 390 studies reached it within 50 months; a quarter within 25 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2026
First posted
Sep 3, 2026
StartEst.
Aug 20, 2026
Primary completionEst.
Jan 20, 2027
CompletionEst.
Aug 20, 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07801261
Lead sponsor
Sohag University
Responsible party
Rania Abodaif Mohamed (Resident, Sohag University) — Principal investigator
First posted
Sep 3, 2026
Start date
Aug 20, 2026 (estimated)
Primary completion
Jan 20, 2027 (estimated)
Completion
Aug 20, 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Rania Abudief Mohamed
Contact
rania8abudief@gmail.com
00201015166578

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion